US Stock MarketDetailed Quotes

ALKS Alkermes

Watchlist
  • 23.630
  • -0.130-0.55%
Trading Apr 19 10:21 ET
4.00BMarket Cap11.25P/E (TTM)

About Alkermes Company

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Company Profile

SymbolALKS
Company NameAlkermes
Listing DateSep 19, 2011
Issue Price10.00
Founded2011
CEOMr. Richard F. Pops
MarketNASDAQ
Employees2100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressConnaught House,1 Burlington Road
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-772-8000
Websitehttp://www.alkermes.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard F. Pops
  • Chairman of the Board and Chief Executive Officer
  • 9.44M
  • Christian Todd Nichols
  • Senior Vice President and Chief Commercial Officer
  • --
  • Blair C. Jackson
  • Interim Chief Financial Officer; Executive Vice President and Chief Operating Officer of the Company and Alkermes, Inc.
  • 4.56M
  • David Joseph Gaffin
  • Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer
  • 4.14M
  • Iain M. Brown
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.21M
  • Michael J. Landine
  • Senior Vice President, Corporate Development and Chief Risk Officer
  • --
  • Dr. Craig C. Hopkinson, M.D.
  • Executive Vice President, Research and Development and Chief Medical Officer
  • 4.55M
  • Samuel J. Parisi
  • Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc.
  • --
  • Shane M. Cooke
  • Director; Chairman of the Board of Alkermes Pharma Ireland Limited
  • 449.04K
  • Brian P. Mckeon
  • Independent Director
  • 482.04K
  • David A. Daglio, Jr
  • Independent Director
  • 474.04K
  • Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
  • Independent Director
  • 482.04K
  • Nancy S. Lurker
  • Independent Director
  • --
  • Dr. Christopher I. Wright, M.D.,PhD
  • Independent Director
  • 463.12K
  • Dr. Cato T. Laurencin,M.D.,PhD
  • Independent Director
  • 459.04K
  • Dr. Richard B. Gaynor, M.D.
  • Independent Director
  • 464.69K
  • Emily Peterson Alva
  • Independent Director
  • 469.04K
  • Frank Anders Wilson
  • Independent Director
  • 486.65K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg